Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 5
2010 6
2011 2
2012 7
2013 2
2014 3
2015 5
2016 9
2017 16
2018 9
2019 7
2020 16
2021 11
2022 4
2023 12
2024 10
2025 16
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact.
Albliwi M, Nurse DP, Zabor EC, Hanna J, El-Asmar J, Bawwab A, Abuamsha H, Abu-Farsakh Y, Batah H, Rauf A, Nakitandwe J, Bosler DS, Parthasarathy PB, Alban T, Jain AG, Molina JC, Balderman S, Singh A, Gerds AT, Mukherjee S, Advani AS, Carraway HE, Mustafa Ali MK. Albliwi M, et al. Among authors: carraway he. Cancer. 2026 Jun 1;132(11):e70465. doi: 10.1002/cncr.70465. Cancer. 2026. PMID: 42175603
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Yu K, Dillon LW, Tettero JM, Gui G, Al-Ali RW, Grunwald MR, Krakow EF, Griffiths EA, Gomez-Arteaga A, Vedula RS, Solh M, Salhotra A, Bejanyan N, Muffly L, Jimenez-Jimenez AM, Drazer MW, Chen YB, Logan A, Jayani-Kosarzycki RV, Balderman SR, Blachly JS, Shaffer BC, Druhan LJ, Yeung CC, Kennedy VE, Fathi AT, Carraway HE, Gurbuxani S, Tjota MY, Sahoo F, Smith M, Barfield D, Guo J, Han J, Hu J, Jo H, Kudlingar V, Li W, Qiu Y, Sathyan P, Truong S, Catreux S, Ng S, Luong K, Zhu Y, Bahr R, Diemer J, Ferrone CK, Getker AJ, Bjerke J, Bo-Subait S, Devine SM, Dietel B, Giammarino G, Chihak EH, Kou J, Kolb E, Vitali DO, Spellman SR, Tesch BK, Vogel J, Waldvogel S, Weatherspoon S, Auletta JJ, Hourigan CS. Yu K, et al. Among authors: carraway he. medRxiv [Preprint]. 2025 Dec 7:2025.12.04.25340141. doi: 10.64898/2025.12.04.25340141. medRxiv. 2025. PMID: 41404287 Free PMC article. Preprint.
Updates in low/intermediate-risk MDS.
Carraway HE. Carraway HE. Hematology Am Soc Hematol Educ Program. 2025 Dec 5;2025(1):699-708. doi: 10.1182/hematology.2025000768. Hematology Am Soc Hematol Educ Program. 2025. PMID: 41348013 Free PMC article. Review.
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States.
Mukherjee S, Dong W, Gerds AT, Carraway HE, Singh A, Advani AS, Mustafa Ali MK, Molina JC, Balderman S, Jain A, Caimi P, Anwer F, Sekeres MA, Koroukian SM. Mukherjee S, et al. Among authors: carraway he. Blood Neoplasia. 2025 Aug 6;2(4):100156. doi: 10.1016/j.bneo.2025.100156. eCollection 2025 Nov. Blood Neoplasia. 2025. PMID: 41146970 Free PMC article.
Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score-Adjusted Cohort Study.
Albliwi M, Zabor EC, Hanna J, El-Asmar J, Nurse DP, Bawwab A, Abuamsha H, Abu-Farsakh Y, Rauf A, Batah H, Mohamed A, Alchirazi MA, Jain AG, Molina JC, Balderman S, Singh A, Gerds AT, Mukherjee S, Sobecks RM, Hamilton B, Advani AS, Carraway HE, Mustafa Ali MK. Albliwi M, et al. Among authors: carraway he. Clin Lymphoma Myeloma Leuk. 2026 Jan;26(1):e41-e49. doi: 10.1016/j.clml.2025.08.016. Epub 2025 Aug 25. Clin Lymphoma Myeloma Leuk. 2026. PMID: 40947327
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.
Aribi A, Mannis GN, Madanat YF, Jonas BA, Dunavin N, Roboz GJ, Jeyakumar D, Garcia-Manero G, Liu H, Carraway HE, Saultz JN, Blum W, Schiller G, Huang T, Woodard P, Klencke B, Liao XC, Xiang H, Pollyea DA, DiNardo CD. Aribi A, et al. Among authors: carraway he. Blood Neoplasia. 2025 Jun 9;2(4):100126. doi: 10.1016/j.bneo.2025.100126. eCollection 2025 Nov. Blood Neoplasia. 2025. PMID: 40919482 Free PMC article. Clinical Trial.
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia.
Ball S, Jain AG, Al Ali N, Aguirre LE, Bewersdorf JP, Kent A, Rose A, Hayden A, Siddon A, Lykon J, Madarang E, Swoboda DM, Padron E, Sweet K, Sallman DA, Lancet J, Carraway HE, Watts J, Zeidan A, Pollyea DA, Komrokji RS. Ball S, et al. Among authors: carraway he. Am J Hematol. 2025 Oct;100(10):1920-1923. doi: 10.1002/ajh.70031. Epub 2025 Aug 7. Am J Hematol. 2025. PMID: 40772639 No abstract available.
Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid Leukemia.
Hanna J, Zabor EC, Albliwi M, El-Asmar J, Nurse DP, Bawwab A, Abuamsha H, Abu-Farsakh Y, Batah H, Rauf A, Nakitandwe J, Bosler DS, Jain AG, Molina JC, Balderman S, Singh A, Gerds AT, Mukherjee S, Sobecks RM, Advani AS, Carraway HE, Astbury C, Mustafa Ali MK. Hanna J, et al. Among authors: carraway he. Am J Hematol. 2025 Sep;100(9):1577-1589. doi: 10.1002/ajh.70000. Epub 2025 Jul 11. Am J Hematol. 2025. PMID: 40642970 Free PMC article.
119 results